Timothy Coté
Directeur Général chez Coté Orphan LLC
Fortune : 10 810 $ au 30/04/2024
Postes actifs de Timothy Coté
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Coté Orphan LLC
 Coté Orphan LLC Miscellaneous Commercial ServicesCommercial Services Coté Orphan LLC is a boutique full-service regulatory group with a laser focus on Orphan Drugs. Its services include FDA orphan designation, EMA orphan designation, strategic reviews, IND filings and NDA, BLA and MAA filings. The company was founded by Timothy R. Cote and is headquartered in Silver Spring, MD. | Directeur Général | - | - |
| Fondateur | - | - |
Historique de carrière de Timothy Coté
Anciens postes connus de Timothy Coté
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SOLIGENIX, INC. | Directeur/Membre du Conseil | 03/05/2023 | 07/07/2023 |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - | - |
| XENETIC BIOSCIENCES, INC. | Directeur/Membre du Conseil | 07/02/2014 | - |
Formation de Timothy Coté
| Syracuse University | Undergraduate Degree |
| Howard University | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| XENETIC BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Coté Orphan LLC
Coté Orphan LLC Miscellaneous Commercial ServicesCommercial Services Coté Orphan LLC is a boutique full-service regulatory group with a laser focus on Orphan Drugs. Its services include FDA orphan designation, EMA orphan designation, strategic reviews, IND filings and NDA, BLA and MAA filings. The company was founded by Timothy R. Cote and is headquartered in Silver Spring, MD. | Commercial Services |
- Bourse
- Insiders
- Timothy Coté
- Expérience